219 related articles for article (PubMed ID: 10698982)
1. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Chang HC; Chang JJ; Huang AH; Chang TC
J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Chang HC; Chang JJ; Chan SH; Huang AH; Wu TL; Lin MC; Chang TC
J Clin Microbiol; 2001 Apr; 39(4):1328-33. PubMed ID: 11283051
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
4. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
[TBL] [Abstract][Full Text] [Related]
6. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
Lu JJ; Lee SY; Chiueh TS
J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
[TBL] [Abstract][Full Text] [Related]
7. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Morace G; Manzara S; Dettori G
Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
[TBL] [Abstract][Full Text] [Related]
10. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
[TBL] [Abstract][Full Text] [Related]
11. Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Avolio M; Grosso S; Bruschetta G; De Rosa R; Camporese A
New Microbiol; 2009 Apr; 32(2):179-84. PubMed ID: 19579696
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.
Hawser SP; Norris H; Jessup CJ; Ghannoum MA
J Clin Microbiol; 1998 May; 36(5):1450-2. PubMed ID: 9574729
[TBL] [Abstract][Full Text] [Related]
13. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
14. Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Anaissie EJ; Paetznick VL; Ensign LG; Espinel-Ingroff A; Galgiani JN; Hitchcock CA; LaRocco M; Patterson T; Pfaller MA; Rex JH; Rinaldi MG
Antimicrob Agents Chemother; 1996 Oct; 40(10):2387-91. PubMed ID: 8891149
[TBL] [Abstract][Full Text] [Related]
15. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
Rodriguez-Tudela JL; Martinez-Suárez JV
J Antimicrob Chemother; 1995 Jun; 35(6):739-49. PubMed ID: 7559186
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
Eraso E; Ruesga M; Villar-Vidal M; Carrillo-Muñoz AJ; Espinel-Ingroff A; Quindós G
Rev Iberoam Micol; 2008 Mar; 25(1):3-6. PubMed ID: 18338919
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
18. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Still JM; Law EJ; Belcher KE; Spencer SA
Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
[TBL] [Abstract][Full Text] [Related]
19. Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
Brouwer N; Kohen J; Jamie J; Vemulpad S
J Microbiol Methods; 2006 Aug; 66(2):234-41. PubMed ID: 16406566
[TBL] [Abstract][Full Text] [Related]
20. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
